Related Experiment Video
Updated: Aug 11, 2026

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
Published on: December 15, 2011
[Necrolytic migratory erythema associated with glucagonoma]
Francisco Mendoza-Guil1, Isabel Hernández-Jurado, Pilar Burkhardt
1Servicio de Dermatología, Hospital Clínico San Cecilio, Pintor Zuloaga 14, 6.o H, 18005 Granada, Spain. mendozafrancisco@wanadoo.es
Abstract:
Glucagonoma is a rare pancreatic tumor that is usually associated with a syndrome that includes diabetes, anemia, weight loss and skin lesions in the form of necrolytic migratory erythema. We present the case of a patient with malignant glucagonoma treated with surgery and octreotide, which manifested with skin lesions. The discussion will review the physiopathology, other causes of necrolytic erythema, diagnosis and differential diagnosis and treatment.
Related Concept Videos
Hypoglycemia and Glucagon
Type I Diabetes III: Clinical Manifestations
Hyperglycemia
Type I Diabetes I: Introduction
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Hypoglycemia

